Company Filing History:
Years Active: 1993-2011
Title: Leonhard Brader: Innovator in Phosphonatosilanes and Cyclic Silazanes
Introduction
Leonhard Brader is a notable inventor based in Fischbachau, Germany. He has made significant contributions to the field of chemistry, particularly in the development of phosphonatosilanes and cyclic silazanes. With a total of 4 patents to his name, Brader's work has had a considerable impact on various industrial applications.
Latest Patents
One of Brader's latest patents is a method for producing phosphonatosilanes. This innovative process involves the reaction of organophosphites with halocarbon-functional silanes. The method enhances the safety of the reaction while increasing space/time yield by continuously or periodically withdrawing the reaction mixture. The withdrawn mixture is then freed of the phosphonatosilane product, and the product-depleted remainder is recycled back into the reaction. This process allows for operation at temperatures of 100°C or lower, making it a significant advancement in the field. Another notable patent involves cyclic silazanes, which further showcases his expertise in chemical innovations.
Career Highlights
Throughout his career, Leonhard Brader has worked with prominent companies in the chemical industry. He has been associated with Consortium für Elektrochemische Industrie GmbH and Wacker Chemie AG. His work in these organizations has contributed to the advancement of chemical processes and products.
Collaborations
Brader has collaborated with several professionals in his field, including Oliver Schäfer and Andreas Bauer. These partnerships have likely enriched his research and development efforts, leading to innovative solutions in chemistry.
Conclusion
Leonhard Brader's contributions to the field of chemistry, particularly through his patents and collaborations, highlight his role as an influential inventor. His innovative methods for producing phosphonatosilanes and cyclic silazanes demonstrate his commitment to advancing chemical processes.